1
Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:January 11, 2016Terminated
Multiple Myeloma and Plasma Cell Neoplasm: 2906 Clinical Trials, Page 1 of 291
Hide Studies Not Open or Pending
2
Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:December 19, 2018Completed
3
Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:July 24, 2020Completed
4
Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:January 16, 2014Completed
5
Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:February 1, 2013Terminated
6
Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:December 6, 2017Completed
7
Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:January 22, 2016Completed
8
O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:June 11, 2010Completed
9
Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:November 16, 2018Terminated
10
Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:November 20, 2015Terminated